Assignee
RHODES PHARMACEUTICALS LP
US·8 granted patents·10 pending applications·3 citations·filing 2013–2025
Top patents by PatentIndex Score
18 records- 0179US10463624B2Controlled release formulationsRHODES PHARMACEUTICALS LP·Filed 2017·Granted Nov 5, 2019·1 cites·32 claims
- 0277US2024423974A1Tamper Resistant Immediate Release FormulationsRHODES PHARMACEUTICALS LP·Filed 2024·Application pending·0 cites
- 0376US11564918B2Pharmaceutical resinate compositions and methods of making and using thereofRHODES PHARMACEUTICALS LP·Filed 2017·Granted Jan 31, 2023·2 cites·24 claims
- 0475US2025352538A1Pharmaceutical resinate compositions and methods of making and using thereofRHODES PHARMACEUTICALS LP·Filed 2025·Application pending·0 cites
- 0571US12128042B2Tamper resistant immediate release formulationsRHODES PHARMACEUTICALS LP·Filed 2021·Granted Oct 29, 2024·0 cites·23 claims
- 0669US2025375438A1Pharmaceutical resinate compositions and methods of making and using thereofRHODES PHARMACEUTICALS LP·Filed 2025·Application pending·0 cites
- 0769US2023125208A1Pharmaceutical resinate compositions and methods of making and using thereofRHODES PHARMACEUTICALS LP·Filed 2022·Application pending·0 cites
- 0867US10039719B2Methods of treating attention deficit hyperactivity disorderRHODES PHARMACEUTICALS LP·Filed 2017·Granted Aug 7, 2018·0 cites·32 claims
- 0965US10022330B2Methods of preparing oral controlled release formulationsRHODES PHARMACEUTICALS LP·Filed 2016·Granted Jul 17, 2018·0 cites·8 claims
- 1065US2019216797A1Buprenorphine-wafer for drug substitution therapyRHODES PHARMACEUTICALS LP·Filed 2018·Application pending·0 cites
- 1164US9949931B2Methods of treating attention deficit hyperactivity disorderRHODES PHARMACEUTICALS LP·Filed 2016·Granted Apr 24, 2018·0 cites·23 claims
- 1264US2023285388A1Pharmaceutical resinate compositions and methods of making and using thereofRHODES PHARMACEUTICALS LP·Filed 2023·Application pending·0 cites
- 1363US2018008595A1Buprenorphine wafer for drug substitution therapyRHODES PHARMACEUTICALS LP·Filed 2017·Application pending·0 cites
- 1461US9861628B2Buprenorphine-wafer for drug substitution therapyRHODES PHARMACEUTICALS LP·Filed 2016·Granted Jan 9, 2018·0 cites·15 claims
- 1552US2014113889A1Treatment for dry eyeRHODES PHARMACEUTICALS LP·Filed 2013·Application pending·0 cites
- 1650US11690840B2Pharmaceutical resinate compositions and methods of making and using thereofRHODES PHARMACEUTICALS LP·Filed 2018·Granted Jul 4, 2023·0 cites·27 claims
- 1750US2021008079A1Treatment for dry eyeRHODES PHARMACEUTICALS LP·Filed 2020·Application pending·0 cites
- 1835US2017196846A1Methods for treating attention deficit hyperactivity disorder with methylphenidateRHODES PHARMACEUTICALS LP·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →